Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database-Reference-Cited by-同舟云学术

Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database

Published:2013-11-15 Issue:9 Volume:28 Page:1235-1244
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Le Moigne M.¹²³,Sommet A.¹²⁴,Lapeyre-Mestre M.¹²⁴,Bourrel R.⁵,Molinier L.²⁶,Paul C.³,Montastruc J-.L.¹²⁴

Affiliation:

1. Laboratoire de Pharmacologie Médicale et Clinique; Faculté de Médecine; Université Paul Sabatier; Toulouse France

2. UMR1027; Inserm; Toulouse France

3. Service de Dermatologie; Centre Hospitalier Universitaire; Université Paul Sabatier et Hôpital Larrey; Toulouse France

4. Service de Pharmacologie Clinique; Centre Midi-Pyrénées de Pharmacovigilance; de Pharmacoépidémiologie et d'Information sur le Médicament; Centre Hospitalier Universitaire de Toulouse; Toulouse France

5. Caisse Nationale d'Assurance Maladie Midi-Pyrénées; Toulouse France

6. Département d'Information Médicale; Centre Hospitalier Universitaire de Toulouse; Toulouse France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12318/fullpdf

Reference21 articles.

1. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;Prey;J Eur Acad Dermatol Venereol,2010

2. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample;Schmitt;J Eur Acad Dermatol Venereol,2010

3. Prevalence of cardiovascular risk factors in patients with psoriasis;Neimann;J Am Acad Dermatol,2006